HPGDS and Hepatic fibrosis: Our investigation of the role of PGD2 in schistosomal granulomas led to the discovery of unanticipated endogenous counter-regulatory functions required to limit hepatic fibrosis beyond those associated with DP1 receptor activation [19,38,39].